Understanding Diastolic Heart Failure (HFpEF) or Heart Failure with Preserved Ejection Fraction is crucial for accurate clinical documentation and medical coding. This resource provides information on diagnosing and documenting Diastolic Heart Failure with a focus on preserved EF, along with relevant healthcare and medical coding terminology for ICD-10 and other coding systems. Learn about the signs, symptoms, and treatment of HFpEF for improved patient care and optimized clinical workflows.
Also known as
Diastolic heart failure
Heart failure with preserved ejection fraction.
Heart failure
Covers various types of heart failure, including diastolic.
Hypertensive heart disease
High blood pressure affecting the heart, a common cause of diastolic failure.
Cardiomyopathy
Diseases of the heart muscle that can lead to heart failure, including diastolic type.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the EF preserved (>=50%)?
When to use each related code
| Description |
|---|
| Heart pumps normally but doesn't relax during filling. |
| Heart's reduced ability to pump blood effectively. |
| Heart failure with mid-range ejection fraction. |
Coding HFpEF as unspecified heart failure due to documentation lacking details on ejection fraction or other key indicators.
Incorrectly coding comorbidities like hypertension or atrial fibrillation as causative of HFpEF when they are coincidental.
Miscoding acute decompensated heart failure as chronic HFpEF or vice versa, impacting severity and reimbursement.
Q: How can I differentiate between diastolic heart failure (HFpEF) and systolic heart failure (HFrEF) in my clinical practice using echocardiography and natriuretic peptides?
A: Differentiating between HFpEF and HFrEF hinges on assessing left ventricular ejection fraction (LVEF) and diastolic function. In HFpEF (heart failure with preserved ejection fraction), LVEF is normal or near normal (>=50%), but echocardiography reveals impaired relaxation or increased filling pressures, such as elevated E/e' ratio or left atrial enlargement. Conversely, HFrEF (heart failure with reduced ejection fraction) presents with a reduced LVEF (<40%). While natriuretic peptides like BNP and NT-proBNP are often elevated in both, they can be helpful when LVEF is borderline. Consider implementing a stepwise approach using echocardiography for LVEF assessment and diastolic function analysis followed by natriuretic peptide measurement to solidify your diagnosis. Explore how incorporating these tools into your routine can improve diagnostic accuracy and patient outcomes.
Q: What are the most effective evidence-based treatment strategies for managing diastolic heart failure (HFpEF) patients in a primary care setting?
A: Managing HFpEF in primary care involves a multifaceted approach focused on symptom control and addressing comorbidities. Blood pressure control is paramount, often utilizing agents like ACE inhibitors, ARBs, or beta-blockers, tailored to the individual patient's needs and tolerability. Diuretics are essential for managing fluid overload and congestion. Addressing comorbidities like diabetes, sleep apnea, and atrial fibrillation is crucial. Furthermore, lifestyle modifications such as sodium restriction, regular exercise, and weight management play a vital role. Consider implementing a patient-centered approach, discussing the importance of medication adherence and lifestyle changes, and regularly monitoring symptoms and disease progression. Learn more about incorporating recent clinical trial data into your HFpEF management strategies to optimize patient care.
Patient presents with complaints consistent with diastolic heart failure (HFpEF), also known as heart failure with preserved ejection fraction. Symptoms include exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and fatigue. Physical exam reveals elevated jugular venous pressure, S3 heart sound, and pulmonary rales. The patient denies chest pain. Echocardiogram demonstrates normal left ventricular ejection fraction (LVEF) greater than or equal to 50%, but impaired diastolic filling with evidence of left ventricular hypertrophy and elevated left atrial pressure. Diagnosis of HFpEF is made based on these clinical findings and diagnostic testing. Differential diagnoses considered included other causes of dyspnea such as chronic obstructive pulmonary disease (COPD) and asthma, which were ruled out based on pulmonary function testing and clinical presentation. Treatment plan includes diuretics for symptom management, optimization of comorbidities such as hypertension and diabetes, and patient education regarding lifestyle modifications including sodium restriction and fluid management. Follow-up echocardiography and BNP levels will be monitored to assess treatment response. ICD-10 code I50.31 (Diastolic heart failure) is assigned. Patient education provided regarding medication adherence, symptom monitoring, and importance of follow-up appointments. Prognosis discussed with patient.